TAU Systems is developing laser-plasma accelerators to simulate cosmic rays and accelerate testing of electronics.
After years of playing second fiddle to amyloid as a drug target in Alzheimer's disease, there are signs of increasing interest in the development of tau protein-targeting drugs. Earlier this ...
A complementary drug to combat Alzheimer's disease could target a specific part of the nerve cell protein tau.